MyAllies NewsBreakingRegulatoryWorldTechnologyBusinessPoliticsEntertainmentHealthSportsTopics
Home › Regulatory

Immix Biopharma, Inc. - 10-Q Filing

Immix Biopharma reports Q3 2026 financial results including updates on equity incentive plans and securities purchase agreements.

3 articles from 1 source · updated November 12, 2026, 21:16 UTC

Coverage

  • CRESCENT BIOPHARMA, INC. - 8-K Filing SEC EDGAR · November 12, 2026, 21:15 UTC
  • CRESCENT BIOPHARMA, INC. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:11 UTC
  • Immix Biopharma, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 21:05 UTC